Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 43 Carcinoma, Hepatocellular 19 Rectal Neoplasms 10 Colonic Neoplasms 10 Neoplasm Metastasis 9 Gastrointestinal Stromal Tumors 8 Sarcoma 5 Ovarian Neoplasms 5 Melanoma 4 Cholangiocarcinoma 4 Pancreatic Neoplasms 3 Osteosarcoma 3 Liver Neoplasms 3 Glioblastoma 3 Stomach Neoplasms 2 Neoplasms 2 Lung Neoplasms 2 Gallbladder Neoplasms 2 Fatigue 2 Esophageal Neoplasms 2 Colorectal Cancer Metastatic 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Bile Duct Neoplasms 2 Adenocarcinoma 2 Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer) 1 Thyroid Neoplasms 1 Thymoma 1 Squamous Cell Carcinoma of Head and Neck 1 Somatostatinoma 1

Interventions

Oxaliplatin 3 Cetuximab 3 Capecitabine 3 Irinotecan 2 trifluridine tipiracil drug combination 1 surufatinib 1 regorafenib 1 raltitrexed 1 plocabulin 1 nimotuzumab 1 irinotecan sucrosofate 1 endostar protein 1 durvalumab 1 defactinib 1 Panitumumab 1 N-(3-cyano-4-methyl-1H-indol-7-yl)-3-cyanobenzene-sulfonamide 1 Drug Therapy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Colorectal Cancer × regorafenib × Clear all

NCT02619435 2023-03-24

STREAM

National Cancer Institute, Naples

Phase 2 Unknown

Gastrointestinal

Advanced Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡